Novilytic secures $1.6M, preps commercial launch
A made-in-Indiana startup with a tool that could save pharmaceutical companies millions of dollars when it comes to trashing contaminated drugs during the development process. In the Business of Health, Kylie Veleta has more with Novilytic Chief Executive Officer Paul Dreier.
Video Player is loading.
This is a modal window.
The media could not be loaded, either because the server or network failed or because the format is not supported.